We serve Chemical Name:4-Chlor-7-fluorchinolin-3-carbonitril CAS:622369-70-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Chlor-7-fluorchinolin-3-carbonitril
CAS.NO:622369-70-4
Synonyms:4-chloro-7-fluoroquinoline-3-carbonitrile;4-Chlor-7-fluorchinolin-3-carbonitril;4-Chloro-7-fluoro-3-quinolinecarbonitrile;3-Quinolinecarbonitrile, 4-chloro-7-fluoro-;4-chloro-3-cyano-7-fluoro quinoline
Molecular Formula:C10H4ClFN2
Molecular Weight:206.604
HS Code:2933499090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:351.7±37.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.641
PSA:36.68000
Exact Mass:206.004700
LogP:2.41
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-chloro-7-fluoroquinoline-3-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-chloro-3-cyano-7-fluoro quinoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Chloro-7-fluoro-3-quinolinecarbonitrile Use and application,4-chloro-3-cyano-7-fluoro quinoline technical grade,usp/ep/jp grade.
Related News: The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed. 4-Chlor-7-fluorchinolin-3-carbonitril manufacturer The company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. However, the memo did not respond to all concerns employees raised in their April complaint, which Reuters reviewed. 4-Chlor-7-fluorchinolin-3-carbonitril supplier Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. 4-Chlor-7-fluorchinolin-3-carbonitril vendor Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. 4-Chlor-7-fluorchinolin-3-carbonitril factory Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.
